CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- 4 Planned sale Director sold 28,000 shares at an average $80.82 ($2,262,848)
- 4 Planned sale Director sold 12,000 shares at $80.00 ($960,000)
- 4 Planned sale EVP, Chief Human Resources Ofc sold 16,777 shares at $80.91 ($1,357,442)
- 4 Option exercise Director acquired 16,000 shares (option exercise)
- 4 Open-market sale Director sold 44,000 shares at $72.13 ($3,173,830)
- 4 Planned sale EVP, Corp and Development Ops sold 8,000 shares at $76.17 ($609,379)
- 4 Planned sale EVP, Chief Development Officer sold 34,639 shares at an average $75.69 ($2,621,816)
- 4/A Planned sale EVP, Chief Development Officer sold 1,680 shares at $75.05 ($126,091)
- 4 Planned sale Director sold 28,000 shares at an average $74.02 ($2,072,578)
- 4 Planned sale Director sold 16,000 shares at $75.10 ($1,201,669)
- 4 Planned sale EVP, Chief Development Officer sold 90,929 shares at an average $75.11 ($6,829,431)
- 4 Open-market sale EVP Research sold 53 shares at $73.62 ($3,902)
- 4 Planned sale Director sold 5,000 shares at $71.74 ($358,722)
- 4 Planned sale EVP, Chief Human Resources Ofc sold 7,263 shares at an average $73.06 ($530,638)
- 4 Planned sale EVP, Corp and Development Ops sold 23,900 shares at an average $72.13 ($1,723,987)
- 4 Planned sale EVP Research sold 6,849 shares at $69.02 ($472,718)
- 4 Planned sale EVP CLO & General Counsel sold 13,441 shares at an average $69.74 ($937,338)
- 4 Planned sale Chief Executive Officer sold 437 shares at $69.26 ($30,268)
- 4 Planned sale EVP, Chief Business Officer sold 1,625 shares at $69.37 ($112,725)
- 4 Planned sale Director sold 16,800 shares at $65.50 ($1,100,385)
Page 6 of 77 · 1,536 filings